These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27997860)

  • 21. Therapeutic angiogenesis for the management of refractory angina: current concepts.
    Attanasio S; Schaer G
    Cardiovasc Ther; 2011 Dec; 29(6):e1-e11. PubMed ID: 20406245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-214 regulates the pathogenesis of patients with coronary artery disease by targeting VEGF.
    Jin Y; Yang CJ; Xu X; Cao JN; Feng QT; Yang J
    Mol Cell Biochem; 2015 Apr; 402(1-2):111-22. PubMed ID: 25575606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts.
    Hitchon C; Wong K; Ma G; Reed J; Lyttle D; El-Gabalawy H
    Arthritis Rheum; 2002 Oct; 46(10):2587-97. PubMed ID: 12384916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
    Ngan BY; Forte V; Campisi P
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction.
    Clavel G; Bessis N; Lemeiter D; Fardellone P; Mejjad O; Ménard JF; Pouplin S; Boumier P; Vittecoq O; Le Loët X; Boissier MC
    Clin Immunol; 2007 Aug; 124(2):158-64. PubMed ID: 17560831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.
    Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN
    Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.
    Nakamura K; Henry TD; Traverse JH; Latter DA; Mokadam NA; Answini GA; Williams AR; Sun BC; Burke CR; Bakaeen FG; DiCarli MF; Chaitman BR; Peterson MW; Byrnes DG; Ohman EM; Pepine CJ; Crystal RG; Rosengart TK; Kowalewski E; Koch GG; Dittrich HC; Povsic TJ;
    Circ Cardiovasc Interv; 2024 May; 17(5):e014054. PubMed ID: 38696284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis.
    Tepeköylü C; Wang FS; Kozaryn R; Albrecht-Schgoer K; Theurl M; Schaden W; Ke HJ; Yang Y; Kirchmair R; Grimm M; Wang CJ; Holfeld J
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):971-8. PubMed ID: 23395097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the role of angiogenesis in systemic lupus erythematosus.
    Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
    Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of high-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on vascular endothelial growth factor.
    Biscetti F; Flex A; Pecorini G; Angelini F; Arena V; Stigliano E; Gremese E; Tolusso B; Ferraccioli G
    Clin Exp Immunol; 2016 Apr; 184(1):62-72. PubMed ID: 26671547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease.
    Tio RA; Tan ES; Jessurun GA; Veeger N; Jager PL; Slart RH; de Jong RM; Pruim J; Hospers GA; Willemsen AT; de Jongste MJ; van Boven AJ; van Veldhuisen DJ; Zijlstra F
    J Nucl Med; 2004 Sep; 45(9):1437-43. PubMed ID: 15347709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis.
    Anisimov A; Tvorogov D; Alitalo A; Leppänen VM; An Y; Han EC; Orsenigo F; Gaál EI; Holopainen T; Koh YJ; Tammela T; Korpisalo P; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Dejana E; Koh GY; Choi C; Saharinen P; Alitalo K
    Circulation; 2013 Jan; 127(4):424-34. PubMed ID: 23357661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline.
    Brivio F; Lissoni P; Rovelli F; Nespoli A; Uggeri F; Fumagalli L; Gardani G
    Hepatogastroenterology; 2002; 49(44):385-7. PubMed ID: 11995457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression.
    Levanon K; Varda-Bloom N; Greenberger S; Barshack I; Goldberg I; Orenstein A; Breitbart E; Shaish A; Harats D
    Pathobiology; 2006; 73(3):149-58. PubMed ID: 17085959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia.
    Luo JY; Wu GF; Xiong Y; Chen GW; Xie Q; Yang DY; He XH; Zhang Y; Liu DH; Wang KJ; Ma H; Zheng ZS; DU ZM
    Chin Med J (Engl); 2009 May; 122(10):1188-94. PubMed ID: 19493469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up and safety assessment of angiogenic gene therapy trial VIF-CAD: Transcatheter intramyocardial administration of a bicistronic plasmid expressing VEGF-A165/bFGF cDNA for the treatment of refractory coronary artery disease.
    Kukuła K; Urbanowicz A; Kłopotowski M; Dąbrowski M; Pręgowski J; Kądziela J; Chmielak Z; Witkowski A; Rużyłło W
    Am Heart J; 2019 Sep; 215():78-82. PubMed ID: 31288177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.